Advertisement
Screener

Creative Medical Technology Holdings, Inc. (CELZ) Amortization of Intangible Assets

2.8 / 5 stars · 68/120 Roast Me

Creative Medical Technology Holdings, Inc. Amortization of Intangible Assets

Creative Medical Technology Holdings, Inc. (CELZ) reported Amortization of Intangible Assets of $22.92 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-07

  • Creative Medical Technology Holdings, Inc. amortization of intangible assets for the quarter ending 2026-06-30 was $22.92K, a 25.45% decline year-over-year.
  • Creative Medical Technology Holdings, Inc. amortization of intangible assets for the quarter ending 2026-03-31 was $28.86K, a 5.63% decline year-over-year.
  • Creative Medical Technology Holdings, Inc. amortization of intangible assets for the quarter ending 2025-12-31 was $30.95K, a 36.71% increase year-over-year.
  • Creative Medical Technology Holdings, Inc. amortization of intangible assets for the quarter ending 2025-09-30 was $31.06K, a 6.11% increase year-over-year.
  • Creative Medical Technology Holdings, Inc. amortization of intangible assets for fiscal 2025 was $123.33K, a 11.66% increase from fiscal 2024.
  • Creative Medical Technology Holdings, Inc. amortization of intangible assets for fiscal 2024 was $110.45K, a 16.78% increase from fiscal 2023.
  • Creative Medical Technology Holdings, Inc. amortization of intangible assets for fiscal 2023 was $94.58K, a 2.71% increase from fiscal 2022.
  • Creative Medical Technology Holdings, Inc. amortization of intangible assets for fiscal 2022 was $92.08K, a 0.00% change from fiscal 2021.
Period endAmortization of Intangible Assets 0 monthAmortization of Intangible Assets 3 monthAmortization of Intangible Assets 6 monthAmortization of Intangible Assets 9 monthAmortization of Intangible Assets 12 month
2026-06-30$22.92K
10-Q · filed 2026-08-07
$51.77K
10-Q · filed 2026-08-07
$82.72K
derived: sum of 3 quarters · filed 2026-08-07
$113.78K
derived: sum of 4 quarters · filed 2026-08-07
2026-03-31$28.86K
10-Q · filed 2026-05-08
$59.80K
derived: sum of 2 quarters · filed 2026-05-08
$90.86K
derived: sum of 3 quarters · filed 2026-05-08
$121.61K
derived: sum of 4 quarters · filed 2026-08-07
2025-12-31$30.95K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20
$62.01K
derived: sum of 2 quarters · filed 2026-03-20
$92.75K
derived: sum of 3 quarters · filed 2026-08-07
$123.33K
10-K · filed 2026-03-20
2025-09-30$31.06K
10-Q · filed 2025-11-07
$61.80K
derived: sum of 2 quarters · filed 2026-08-07
$92.38K
10-Q · filed 2025-11-07
$115.02K
derived: sum of 4 quarters · filed 2026-08-07
2025-06-30$30.74K
10-Q · filed 2026-08-07
$61.32K
10-Q · filed 2026-08-07
$83.96K
derived: sum of 3 quarters · filed 2026-08-07
$113.23K
derived: sum of 4 quarters · filed 2026-08-07
2025-03-31$30.58K
10-Q · filed 2026-05-08
$53.22K
derived: sum of 2 quarters · filed 2026-05-08
$82.49K
derived: sum of 3 quarters · filed 2026-05-08
$111.76K
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31$22.64K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20
$51.91K
derived: sum of 2 quarters · filed 2026-03-20
$81.18K
derived: sum of 3 quarters · filed 2026-03-20
$110.45K
10-K · filed 2026-03-20
2024-09-30$29.27K
10-Q · filed 2025-11-07
$58.54K
derived: sum of 2 quarters · filed 2025-11-07
$87.81K
10-Q · filed 2025-11-07
$113.33K
derived: sum of 4 quarters · filed 2025-11-07
2024-06-30$29.27K
10-Q · filed 2025-08-08
$58.54K
10-Q · filed 2025-08-08
$84.06K
derived: sum of 3 quarters · filed 2025-08-08
$107.08K
derived: sum of 4 quarters · filed 2025-08-08
2024-03-31$29.27K
10-Q · filed 2025-05-09
$54.79K
derived: sum of 2 quarters · filed 2025-05-09
$77.81K
derived: sum of 3 quarters · filed 2025-05-09
$100.83K
derived: sum of 4 quarters · filed 2025-05-09
2023-12-31$25.52K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14
$48.54K
derived: sum of 2 quarters · filed 2025-03-14
$71.56K
derived: sum of 3 quarters · filed 2025-03-14
$94.58K
10-K · filed 2025-03-14
2023-09-30$23.02K
10-Q · filed 2024-11-08
$46.04K
derived: sum of 2 quarters · filed 2024-11-08
$69.06K
10-Q · filed 2024-11-08
$92.08K
derived: sum of 4 quarters · filed 2024-11-08
2023-06-30$23.02K
10-Q · filed 2024-08-09
$46.04K
10-Q · filed 2024-08-09
$69.06K
derived: sum of 3 quarters · filed 2024-08-09
$92.08K
derived: sum of 4 quarters · filed 2024-08-09
2023-03-31$23.02K
10-Q · filed 2024-05-10
$46.04K
derived: sum of 2 quarters · filed 2024-05-10
$69.06K
derived: sum of 3 quarters · filed 2024-05-10
$92.08K
derived: sum of 4 quarters · filed 2024-05-10
2022-12-31$23.02K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22
$46.04K
derived: sum of 2 quarters · filed 2024-03-22
$69.06K
derived: sum of 3 quarters · filed 2024-03-22
$92.08K
10-K · filed 2024-03-22
2022-09-30$23.02K
10-Q · filed 2023-11-14
$46.04K
derived: sum of 2 quarters · filed 2023-11-14
$69.06K
10-Q · filed 2023-11-14
$92.08K
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30$23.02K
10-Q · filed 2023-08-11
$46.04K
10-Q · filed 2023-08-11
$69.06K
derived: sum of 3 quarters · filed 2023-08-11
$92.08K
derived: sum of 4 quarters · filed 2023-08-11
2022-03-31$23.02K
10-Q · filed 2023-05-12
$46.04K
derived: sum of 2 quarters · filed 2023-05-12
$69.06K
derived: sum of 3 quarters · filed 2023-05-12
$92.08K
derived: sum of 4 quarters · filed 2023-05-12
2021-12-31$23.02K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
$46.04K
derived: sum of 2 quarters · filed 2023-03-31
$69.06K
derived: sum of 3 quarters · filed 2023-03-31
$92.08K
10-K · filed 2023-03-31
2021-09-30$23.02K
10-Q · filed 2022-11-10
$46.04K
derived: sum of 2 quarters · filed 2022-11-10
$69.06K
10-Q · filed 2022-11-10
$85.83K
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30$23.02K
10-Q · filed 2022-08-12
$46.04K
10-Q · filed 2022-08-12
$62.81K
derived: sum of 3 quarters · filed 2022-08-12
$79.58K
derived: sum of 4 quarters · filed 2022-08-12
2021-03-31$23.02K
10-Q · filed 2022-05-13
$39.79K
derived: sum of 2 quarters · filed 2022-05-13
$56.56K
derived: sum of 3 quarters · filed 2022-05-13
$73.04K
derived: sum of 4 quarters · filed 2022-05-13
2020-12-31$16.77K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30
$33.54K
derived: sum of 2 quarters · filed 2022-03-30
$50.02K
derived: sum of 3 quarters · filed 2022-03-30
$66.79K
10-K · filed 2022-03-30
2020-09-30$16.77K
10-Q · filed 2021-11-15
$33.25K
derived: sum of 2 quarters · filed 2021-11-15
$50.02K
10-Q · filed 2021-11-15
$61.11K
derived: sum of 4 quarters · filed 2021-11-15
2020-06-30$16.48K
10-Q · filed 2021-08-16
$33.25K
10-Q · filed 2021-08-16
$44.34K
derived: sum of 3 quarters · filed 2021-08-16
$49.63K
derived: sum of 4 quarters · filed 2021-08-16
2020-03-31$16.77K
10-Q · filed 2021-05-17
$27.86K
derived: sum of 2 quarters · filed 2021-05-17
$33.15K
derived: sum of 3 quarters · filed 2021-05-17
$38.44K
derived: sum of 4 quarters · filed 2021-05-17
2019-12-31$11.09K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17
$16.38K
derived: sum of 2 quarters · filed 2021-03-17
$21.66K
derived: sum of 3 quarters · filed 2021-03-17
$26.95K
10-K · filed 2021-03-17
2019-09-30$5.29K
10-Q · filed 2020-11-13
$10.57K
derived: sum of 2 quarters · filed 2020-11-13
$15.86K
10-Q · filed 2020-11-13
$21.14K
derived: sum of 4 quarters · filed 2020-11-13
2019-06-30$5.29K
10-Q · filed 2020-08-14
$10.57K
10-Q · filed 2020-08-14
$15.86K
derived: sum of 3 quarters · filed 2020-08-14
$21.14K
derived: sum of 4 quarters · filed 2020-08-14
2019-03-31$5.29K
10-Q · filed 2020-05-15
$10.57K
derived: sum of 2 quarters · filed 2020-05-15
$15.86K
derived: sum of 3 quarters · filed 2020-05-15
$21.14K
derived: sum of 4 quarters · filed 2020-05-15
2018-12-31$5.29K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-06
$10.57K
derived: sum of 2 quarters · filed 2020-04-06
$15.86K
derived: sum of 3 quarters · filed 2020-04-06
$21.14K
10-K · filed 2020-04-06
2018-09-30$5.29K
10-Q · filed 2019-11-14
$10.57K
derived: sum of 2 quarters · filed 2019-11-14
$15.86K
10-Q · filed 2019-11-14
$21.14K
derived: sum of 4 quarters · filed 2019-11-14
2018-06-30$5.29K
10-Q · filed 2019-08-13
$10.57K
10-Q · filed 2019-08-13
$15.86K
derived: sum of 3 quarters · filed 2019-08-13
$21.14K
derived: sum of 4 quarters · filed 2019-08-13
2018-03-31$5.29K
10-Q · filed 2019-05-20
$10.57K
derived: sum of 2 quarters · filed 2019-05-20
$15.86K
derived: sum of 3 quarters · filed 2019-05-20
$18.64K
derived: sum of 4 quarters · filed 2019-05-20
2017-12-31$5.29K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01
$10.57K
derived: sum of 2 quarters · filed 2019-04-01
$13.36K
derived: sum of 3 quarters · filed 2019-04-01
$15.99K
10-K · filed 2019-04-01
2017-09-30$5.29K
10-Q · filed 2018-11-14
$8.07K
derived: sum of 2 quarters · filed 2018-11-14
$10.71K
10-Q · filed 2018-11-14
$13.35K
derived: sum of 4 quarters · filed 2018-11-14
2017-06-30$2.79K
10-Q · filed 2018-08-14
$5.42K
10-Q · filed 2018-08-14
$8.06K
derived: sum of 3 quarters · filed 2018-08-14
$10.70K
derived: sum of 4 quarters · filed 2018-08-14
2017-03-31$2.64K
10-Q · filed 2018-08-03
$5.27K
derived: sum of 2 quarters · filed 2018-08-03
$7.91K
derived: sum of 3 quarters · filed 2018-08-03
$10.40K
derived: sum of 4 quarters · filed 2018-08-03
2016-12-31$2.64K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29
$5.27K
derived: sum of 2 quarters · filed 2018-03-29
$7.77K
derived: sum of 3 quarters · filed 2018-03-29
$9.36K
10-K · filed 2018-03-29
2016-09-30$2.64K
10-Q · filed 2017-11-13
$5.13K
derived: sum of 2 quarters · filed 2017-11-13
$6.72K
10-Q · filed 2017-11-13
2016-06-30$2.49K
10-Q · filed 2017-08-14
$4.08K
10-Q · filed 2017-08-14
2016-03-31$1.59K
10-Q · filed 2017-05-10
2015-12-31$0.00
10-K · filed 2017-02-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
AIM ImmunoTech Inc. (AIM)United States$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
VivoSim Labs, INC. (VIVS)United States$0.003B
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
CURIS INC (CRIS)United States$0.002B-0.05
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
Silexion Therapeutics Corp (SLXN)$0.001B